FDA.reportPublic FDA data

Hepatitis B virus e-antigen IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of Hepatitis B virus e-antigen in a clinical specimen.
GUDID devices
6
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
07613336154298PreciControl HBeAgRoche Diagnostics GmbH118763761602018-02-22
08056771103411LIAISON XL MUREX Control HBeAgDIASORIN SPA3181512021-04-13
28056771103415LIAISON XL MUREX Control HBeAgDIASORIN SPA3181512021-04-13
00847661002857VIROTROLBIO-RAD LABORATORIES, INC.001442020-09-14
04015630934843Elecsys PreciControl HBeAgRoche Diagnostics GmbH118763761602014-09-05
00816784020291ACCURUN®Lgc Clinical Diagnostics, Inc.2015-00712018-09-24